Evolution loves history

In order to linkurl:evolve;http://www.the-scientist.com/news/display/23321/ novel traits, organisms may depend upon smaller, less dramatic mutations that they amass through their evolutionary history rather than suddenly acquiring a single mutation that gives them drastically different phenotypes, according to a study published online today (Jun 2) in __PNAS__. Whether an organism arrives at major evolutionary innovations through a single key mutation or a history of many accumulated mutations

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
In order to linkurl:evolve;http://www.the-scientist.com/news/display/23321/ novel traits, organisms may depend upon smaller, less dramatic mutations that they amass through their evolutionary history rather than suddenly acquiring a single mutation that gives them drastically different phenotypes, according to a study published online today (Jun 2) in __PNAS__. Whether an organism arrives at major evolutionary innovations through a single key mutation or a history of many accumulated mutations has been hotly debated by evolutionary biologists. The findings are "perhaps the most rigorous, clear-cut demonstration of the role of historical contingency," in evolution, said linkurl:Richard Lenski;https://www.msu.edu/user/lenski/ of Michigan State University, the study's main author. Examining linkurl:__E. coli__;http://www.the-scientist.com/2007/3/1/65/2/ cultures that his lab has maintained since 1988, Lenski found that one population of the bacterium had evolved the ability to metabolize citrate -- an unprecedented trait -- after more than 30,000 generations, or approximately 15 years. So Lenski and his colleagues consulted their "frozen fossil record," consisting of preserved individuals collected from the bacterial population at several points throughout its evolution. They revived bacteria from different stages of the population's 20-year evolution and "replayed" evolution in each. Clones sampled in the first 15,000 generations never evolved the ability to metabolize citrate (Cit+), while clones taken from later populations did evolve the characteristic. That means this big evolutionary jump relied on a chain of genetic events that took place over the course of the population's evolutionary history, Lenski said. "It's a very elegant demonstration that major changes may depend on accretion of minor changes before hand," said linkurl:Albert Bennett,;http://www.faculty.uci.edu/profile.cfm?faculty_id=4546&name=Albert%20F.%20Bennett%20http://www.youtube.com/watch?v=cE2wHXkVxXY a University of California, Irvine evolutionary physiologist who gave Lenski feedback on the study before it was published in __PNAS__. "What's really demonstrated here is that the way has to be paved before hand." Lenski and his collaborators suggested two possible mechanisms that could have lead to the Cit+ phenotype: the population either accumulated interacting mutations that added up to the functional ability to metabolize citrate, or random mutations, such as insertions, created altered DNA substrates that were then subjected to further mutations, yielding the unique facility. Both Lenski and Bennett said that they tend towards the former, functional, explanation for the evolutionary jump. "Presumably, this is how metabolic pathways got built up," said Bennett. Lenski cautions, however, that his findings do not fully resolve the question of whether evolution is a result of random or deterministic processes. "The real world is a mixture of these two processes," he said. "We're able to see the importance of both perspectives simultaneously." Still, the results suggest that major evolutionary advances are likely to depend on the past evolutionary history of an organism. "This suggests that key innovations may be things that are historically contingent," Lenski said. The researcher now plans to delve deeper into his evolutionary reconstruction experiments, elucidating exactly which mutations led directly to the Cit+ phenotype in his __E. coli__ population. "The key will be to find the one or more mutations that, at the time they occurred, produced the citrate mutation," he said. Lenski will also turn the dial further back to identify those mutations that preceded the emergence of the Cit+ trait. "It's going to be rather tricky to sort out which mutations it was," admitted the researcher.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo